EUVIMEDEUVIMED entdecken
Crossref

Super-Refractory Status Epilepticus in Autoimmune Encephalitis: Predictors and Outcome

R. Krishnan A. Swathy, Ramshekhar N. Menon, Ashalatha Radhakrishnan, R. Madhavan Nayar

International Journal of Epilepsy · 01.08.2026 · 12 (S 01 S 01) · S3-S35

DOI: 10.1055/s-0046-1825909 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Epilepsy, erschienen am 01.08.2026. Verfasst von R. Krishnan A. Swathy und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Super-refractory status epilepticus (SRSE) is the most devastating complication of autoimmune encephalitis (AIE). While the morbidity of AIE-driven status is recognized, data quantifying independent early clinical predictors remains scarce, leading to critical delays in immunomodulatory escalation.

Objective

To identify independent baseline predictors of SRSE in AIE and evaluate longitudinal functional recovery to guide neurocritical care.

Methods

A retrospective cohort study of 222 patients meeting the Graus criteria for AIE was conducted at a tertiary referral center (2015–2024). Patients were stratified into SRSE ( n = 17) and non-SRSE ( n = 205) cohorts. To mitigate quasi-complete separation, variables with 100% prevalence were excluded from multivariable analysis. A multivariate logistic regression model quantified independent risk factors. Functional outcomes were assessed longitudinally using the modified Rankin Scale (mRS).

Results

SRSE occurred in 7.6% of the cohort, exclusively within seronegative or nonclassical antibody presentations. In multivariate analysis adjusting for early clinical and radiological signs, severe encephalopathy at presentation (Glasgow Coma Scale 2) at discharge. However, longitudinal tracking revealed a profound delayed-recovery phenotype. By 1 year, the rate of good functional outcomes (mRS 0–2) in surviving SRSE patients (83.3%) achieved statistical equivalence with the non-SRSE cohort (92.3%, p = 0.582).

Conclusion

Early encephalopathy and abnormal neuroimaging are powerful independent predictors of SRSE. Despite catastrophic acute morbidity, sustained neurocritical care and early immunomodulation yield excellent, long-term functional reversibility. Publication History Article published online: 15 July 2026 © 2026. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Thieme Medical and Scientific Publishers Private Limited A-13A, Graphix Tower 1, 6th floor, Sector 62, Noida 201309, Uttar Pradesh, India

Zitieren

APA

Swathy, R. K. A., Menon, R. N., Radhakrishnan, A., & Nayar, R. M. (2026). Super-Refractory Status Epilepticus in Autoimmune Encephalitis: Predictors and Outcome. International Journal of Epilepsy, 12(S 01 S 01), S3-S35. https://doi.org/10.1055/s-0046-1825909

Vancouver

Swathy RKA, Menon RN, Radhakrishnan A, Nayar RM. Super-Refractory Status Epilepticus in Autoimmune Encephalitis: Predictors and Outcome. International Journal of Epilepsy. 2026;12(S 01 S 01):S3-S35. doi:10.1055/s-0046-1825909

BibTeX
@article{Swathy2026,
  author = {Swathy, R. Krishnan A. and Menon, Ramshekhar N. and Radhakrishnan, Ashalatha and Nayar, R. Madhavan},
  title = {Super-Refractory Status Epilepticus in Autoimmune Encephalitis: Predictors and Outcome},
  journal = {International Journal of Epilepsy},
  year = {2026},
  volume = {12},
  number = {S 01 S 01},
  pages = {S3--S35},
  doi = {10.1055/s-0046-1825909}
}
Kostenlos starten →